Evidence map›Paper›PMID 42261773›Full record

ArticleJournal of proteome research2026

ProteoForge: An Imputation-Aware Framework for Differential Proteoform Discovery in Bottom-Up Proteomics.

Enes K Ergin, Agustina Conrrero, Kirsty M Ferguson, Philipp F Lange

Abstract read
In one paragraph

Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Enes K ErginDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 1M9, Canada.
Agustina ConrreroMichael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, British Columbia V5Z 4H4, Canada.
Kirsty M FergusonDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 1M9, Canada.
Philipp F LangeDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 1M9, Canada.ORCID 0000-0003-1171-5864

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human genome contains approximately 20,000 protein-coding genes. However, millions of diverse protein variants, called proteoforms, exist. Despite originating from the same gene, proteoforms often have distinct biological roles. In bottom-up proteomics, the aggregation of peptide measurements into protein-level quantities often obscures this information. Existing methods for differential proteoform discovery are limited by their handling of missing data, which can introduce a significant bias. To address this, we developed ProteoForge, which builds on an imputation-aware statistical model to identify and group covarying peptides into quantitatively differential proteoforms (dPFs). Benchmarking against existing methods demonstrated that ProteoForge provides high accuracy and stability in data sets with high rates of missing values, complex experimental designs, or varying signal strengths. Application of ProteoForge to proteomics data from lung cancer cells under hypoxia revealed extensive proteoform-level regulation hidden by a standard protein-level analysis.

Indexed as

ProteomeProteomicsSoftwareCell Line, TumorComputational BiologyHumansLung NeoplasmsPeptidesPeptidesProteomeBioinformaticsDifferential DiscoveryHypoxiaProteoformProteomicsQuantification

Identifiers

PMID42261773
PMCPMC13340428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.